Table 7.
Risk of complications in comparing AGV with BGI
| Complications | No. of studies | Crude data (n/N) | OR (95 % CI) | Heterogeneity | Test for over effect (P) | ||
|---|---|---|---|---|---|---|---|
| AGV | BGI | I2 (%) | P | ||||
| Total (eyes) | 8 | 158/443 | 199/528 | 0.67 (0.50, 0.90) | 0 | 0.88 | 0.007 |
| Severe complication (cases) | 8 | 34/443 | 58/528 | 0.57 (0.36, 0.91) | 0 | 0.83 | 0.02 |
| Hypotony (cases) | 6 | 18/316 | 34/408 | 0.54 (0.26, 1.11) | 5 | 0.38 | 0.1 |
| Tube complication (cases) | 4 | 28/317 | 40/303 | 0.68 (0.25, 1.87) | 56 | 0.08 | 0.46 |
| Hyphema (cases) | 4 | 23/317 | 33/303 | 0.64 (0.36, 1.13) | 0 | 0.58 | 0.12 |
| Choroidal effusion (cases) | 5 | 40/336 | 38/357 | 1.10 (0.72, 1.69) | 0 | 0.62 | 0.66 |